Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Foresee Pharmaceuticals Co. Ltd. has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is concentrated with 1 examiner in 1 art unit, and MAYHEW, BRADLEY SCOTT is the identified examiner handling the pending action.
The matching examiner and art-unit figures indicate a focused prosecution channel rather than a portfolio distributed across multiple examination groups. Counsel can therefore direct review toward the record before MAYHEW, BRADLEY SCOTT and the practices associated with the assigned unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MAYHEW, BRADLEY SCOTT | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18510915 | DEPOT COMPOSITIONS FOR VESICULAR MONOAMINE TRANSPORTER 2 (VMAT2) INHBITORS | MAYHEW, BRADLEY SCOTT | — |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18510915 | DEPOT COMPOSITIONS FOR VESICULAR MONOAMINE TRANSPORTER 2 (VMAT2) INHBITORS | MAYHEW, BRADLEY SCOTT | 1621 | §102§103§112 | Final Rejection | — | Pending | Nov 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialForesee Pharmaceuticals Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Bradley Scott Mayhew has the most, with 1 of Foresee Pharmaceuticals Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.